Open Access. Powered by Scholars. Published by Universities.®
Articles 1 - 12 of 12
Full-Text Articles in Medicine and Health Sciences
A Proud Huntington’S Disease Gene Carrier’S Message To His 'Miracle Baby' Daughter On Her Senior Year In College, Kenneth P. Serbin
A Proud Huntington’S Disease Gene Carrier’S Message To His 'Miracle Baby' Daughter On Her Senior Year In College, Kenneth P. Serbin
At Risk for Huntington's Disease
No abstract provided.
Bidding Farewell To My ‘Mind Coach,’ A Major Ally In My Fight To Avoid Huntington's Disease, Kenneth P. Serbin
Bidding Farewell To My ‘Mind Coach,’ A Major Ally In My Fight To Avoid Huntington's Disease, Kenneth P. Serbin
At Risk for Huntington's Disease
No abstract provided.
Crispr, Curing Huntington’S Disease, And Humanity’S Future In Isaacson's 'Code Breaker', Kenneth P. Serbin
Crispr, Curing Huntington’S Disease, And Humanity’S Future In Isaacson's 'Code Breaker', Kenneth P. Serbin
At Risk for Huntington's Disease
No abstract provided.
‘Inequality Is Unsustainable’: A View Of The Quest For Huntington's Disease Treatments From The Global South, Kenneth P. Serbin
‘Inequality Is Unsustainable’: A View Of The Quest For Huntington's Disease Treatments From The Global South, Kenneth P. Serbin
At Risk for Huntington's Disease
No abstract provided.
‘The First At-Bat Is Never A Grand Slam’: How Huntington's Disease Drug Research Has Matured With The Roche And Wave Setbacks, Kenneth P. Serbin
‘The First At-Bat Is Never A Grand Slam’: How Huntington's Disease Drug Research Has Matured With The Roche And Wave Setbacks, Kenneth P. Serbin
At Risk for Huntington's Disease
No abstract provided.
Roche Confirms Tominersen As Ineffective, While Triplet Provides Key Details For Trial Of Drug To Slow Major Driver Of Huntington's Disease, Kenneth P. Serbin
Roche Confirms Tominersen As Ineffective, While Triplet Provides Key Details For Trial Of Drug To Slow Major Driver Of Huntington's Disease, Kenneth P. Serbin
At Risk for Huntington's Disease
No abstract provided.
With Proof-Hd In The Lead, The Huntington’S Disease Drug Pipeline Is Still 'Full Of Hope' (Coping With Disappointing Clinical Trial Results – Part Ii), Kenneth P. Serbin
With Proof-Hd In The Lead, The Huntington’S Disease Drug Pipeline Is Still 'Full Of Hope' (Coping With Disappointing Clinical Trial Results – Part Ii), Kenneth P. Serbin
At Risk for Huntington's Disease
No abstract provided.
Overcoming A ‘Heartbreaking’ Moment For The Huntington's Disease Cause (Coping With Disappointing Clinical Trial Results – Part I), Kenneth P. Serbin
Overcoming A ‘Heartbreaking’ Moment For The Huntington's Disease Cause (Coping With Disappointing Clinical Trial Results – Part I), Kenneth P. Serbin
At Risk for Huntington's Disease
No abstract provided.
Tough News For Huntington’S, Other Neurological Disease Patients: Roche Halts Dosing In Historic Clinical Trials On Signs Of Inefficacy, Kenneth P. Serbin
Tough News For Huntington’S, Other Neurological Disease Patients: Roche Halts Dosing In Historic Clinical Trials On Signs Of Inefficacy, Kenneth P. Serbin
At Risk for Huntington's Disease
No abstract provided.
Blog Article No. 300: Who Exactly Is Gene Veritas?, Kenneth P. Serbin
Blog Article No. 300: Who Exactly Is Gene Veritas?, Kenneth P. Serbin
At Risk for Huntington's Disease
No abstract provided.
Getting The Covid-19 Vaccine And A New Exercise Bike To Keep Stable In The Fight Against Huntington's Disease, Kenneth P. Serbin
Getting The Covid-19 Vaccine And A New Exercise Bike To Keep Stable In The Fight Against Huntington's Disease, Kenneth P. Serbin
At Risk for Huntington's Disease
No abstract provided.
My Arduous, Lucky, And Enlightening Journey Since My Mother's Death From Huntington's Disease 15 Years Ago, Kenneth P. Serbin
My Arduous, Lucky, And Enlightening Journey Since My Mother's Death From Huntington's Disease 15 Years Ago, Kenneth P. Serbin
At Risk for Huntington's Disease
No abstract provided.